145 related articles for article (PubMed ID: 6124326)
41. Acute haemodynamic effects of oral prenalterol in severe heart failure.
Petch MC; Wisbey C; Ormerod O; Scott C; Goodfellow RM
Br Heart J; 1984 Jul; 52(1):49-52. PubMed ID: 6146324
[TBL] [Abstract][Full Text] [Related]
42. Beta-adrenergic stimulation of the failing ventricle: a double-blind, randomized trial of sustained oral therapy with prenalterol.
Roubin GS; Choong CY; Devenish-Meares S; Sadick NN; Fletcher PJ; Kelly DT; Harris PJ
Circulation; 1984 May; 69(5):955-62. PubMed ID: 6142775
[TBL] [Abstract][Full Text] [Related]
43. Pharmacodynamic effects of prenalterol in healthy subjects.
Johnsson G
Acta Med Scand Suppl; 1982; 659():109-22. PubMed ID: 6127882
[TBL] [Abstract][Full Text] [Related]
44. The haemodynamic effects of intravenous prenalterol and ouabain in conscious dogs.
Ek L; Björkman JA; Carlsson E; Johansson B
Acta Med Scand Suppl; 1982; 659():39-52. PubMed ID: 6127899
[TBL] [Abstract][Full Text] [Related]
45. Haemodynamic effects of prenalterol in acute myocardial ischaemia in open chest pigs.
Branzi A; Binetti G; Specchia S; Magelli C; Zannoli R; Magnani B
Clin Exp Pharmacol Physiol; 1983; 10(3):219-27. PubMed ID: 6627738
[TBL] [Abstract][Full Text] [Related]
46. A comparison of the hemodynamic effects of prenalterol and isoprenaline in patients with complete heart block.
Svendsen TL; Pelle H; Lønholt C; Bonde J; Kampmann JP; Lindeneg O
J Cardiovasc Pharmacol; 1984; 6(4):693-6. PubMed ID: 6206327
[TBL] [Abstract][Full Text] [Related]
47. Long-term hemodynamic effects of prenalterol in patients with severe congestive heart failure.
Lambertz H; Meyer J; Erbel R
Circulation; 1984 Feb; 69(2):298-305. PubMed ID: 6140091
[TBL] [Abstract][Full Text] [Related]
48. Prenalterol as long-term therapy for chronic congestive heart failure. A randomized cross-over trial.
Dahlström U; Areskog M; Wranne B; Karlsson E
Acta Med Scand; 1984; 216(2):199-207. PubMed ID: 6149671
[TBL] [Abstract][Full Text] [Related]
49. Effect of prenalterol on contractility, relaxation, and filling phase in coronary artery disease patients with previous myocardial infarction.
Cucchini F; Baldi G; Bolognesi R; Ferrari R; Visioli O
J Cardiovasc Pharmacol; 1984; 6(5):822-8. PubMed ID: 6209486
[TBL] [Abstract][Full Text] [Related]
50. The haemodynamic effects of dopamine and prenalterol in patients after cardiac valve surgery.
Tydén H; Johansson L; Nyström SO
Acta Anaesthesiol Scand; 1982 Oct; 26(5):468-73. PubMed ID: 6128857
[TBL] [Abstract][Full Text] [Related]
51. Basic pharmacological properties of prenalterol.
Mattsson H; Hedberg A; Carlsson E
Acta Med Scand Suppl; 1982; 659():9-37. PubMed ID: 6127902
[No Abstract] [Full Text] [Related]
52. Contractile, coronary, and metabolic effects of the acute and long-term treatment of cardiac failure with prenalterol.
Strauer BE; Bohn I; Hahn B; Kment A; Motz U
J Cardiovasc Pharmacol; 1984; 6(3):491-8. PubMed ID: 6202977
[TBL] [Abstract][Full Text] [Related]
53. Haemodynamic and cardiac metabolic effects of the new beta 1 agonist prenalterol in patients with cardiac failure.
Kupper W; Schütt M; Hamm CW; Kuck KH; Hanrath P; Bleifeld W
Eur Heart J; 1983 Aug; 4(8):573-83. PubMed ID: 6139281
[TBL] [Abstract][Full Text] [Related]
54. [Prenalterol (CGP 7760 B), a new cardioselective beta 1-adrenoceptor-agonist (author's transl)].
Piepenbrock S; Reichelt W; Zenz M; Seitz W; Sikalieh E
Anaesthesist; 1981 Mar; 30(3):118-23. PubMed ID: 6111933
[TBL] [Abstract][Full Text] [Related]
55. Ventilatory and haemodynamic effects of prenalterol and terbutaline in asthmatic patients.
Greefhorst AP; van Herwaarden CL
Eur J Clin Pharmacol; 1983; 24(2):173-8. PubMed ID: 6132819
[TBL] [Abstract][Full Text] [Related]
56. Hemodynamic effects of intravenous prenalterol in patients on long-term digoxin therapy for congestive heart failure.
Dahlström U; Karlsson E; Wranne B
Eur Heart J; 1982 Aug; 3(4):331-8. PubMed ID: 7128622
[No Abstract] [Full Text] [Related]
57. [The use of beta-1-adrenergic agonists in the treatment of cardiac insufficiency].
Coulombe D
Ann Cardiol Angeiol (Paris); 1984; 33(4):207-10. PubMed ID: 6147113
[TBL] [Abstract][Full Text] [Related]
58. Influence of heart rate on the effects of prenalterol on regional myocardial blood flow and function during coronary stenosis in dogs.
Berdeaux A; Bonhenry C; Duhazé P; Giudicelli JF; Thuillez C
Br J Pharmacol; 1984 Sep; 83(1):203-10. PubMed ID: 6148979
[TBL] [Abstract][Full Text] [Related]
59. [New drugs with positive inotropic action].
Bijak A; Czołpiński T
Kardiol Pol; 1982; 25(4):357-65. PubMed ID: 6128439
[No Abstract] [Full Text] [Related]
60. Effect of prenalterol on orthostatic hypotension in the Shy-Drager syndrome.
Goovaerts J; Verfaillie C; Fagard R; Knockaert D
Br Med J (Clin Res Ed); 1984 Mar; 288(6420):817-8. PubMed ID: 6142747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
